Scienture Holdings, Inc. (SCNX) Financial Ratios
20 years of historical data (2006–2025) · Healthcare · Medical - Healthcare Information Services
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
0.00
↓-99% vs avg
5yr avg: 0.14
30Y Low0.0·High0.3
ROE
↑
-0.1%
↓+100% vs avg
5yr avg: -852.6%
30Y Low-239%·High23%
Debt/EBITDA
N/A
—
5yr avg: N/A
30Y Low1.5·High12.7
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
SCNX Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Scienture Holdings, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $155M | $78M | $22M | — | — | — | — | — | — | — | — |
| Enterprise Value | $179M | $102M | $25M | — | — | — | — | — | — | — | — |
| P/E Ratio → | -0.14 | — | 2.44 | — | — | — | — | — | — | — | — |
| P/S Ratio | 359.42 | 181.35 | 161.77 | — | — | — | — | — | — | — | — |
| P/B Ratio | 0.00 | 0.00 | 0.28 | — | — | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
SCNX EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 236.56 | 185.36 | — | — | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
SCNX Profitability
Margins and return-on-capital ratios measuring operating efficiency
Scienture Holdings, Inc. earns an operating margin of -3763.8%. Operating margins have compressed from -322.4% to -3763.8% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -0.1% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 76.8% | 76.8% | 4.4% | 3.6% | 53.8% | 48.0% | 33.3% | 65.5% | 88.3% | 100.0% | 99.3% |
| Operating Margin | -3763.8% | -3763.8% | -10758.7% | -322.4% | -28.4% | -53.5% | -14.6% | 1.7% | -2.3% | 13.5% | -40.6% |
| Net Profit Margin | -9618.0% | -9618.0% | 6634.7% | -1308.3% | -33.9% | -53.8% | -14.8% | -3.8% | 0.2% | 9.9% | -111.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -0.1% | -0.1% | 22.8% | -4031.4% | -168.8% | -85.4% | -39.6% | -11.4% | 3.4% | — | — |
| ROA | -0.1% | -0.1% | 15.4% | -219.7% | -73.3% | -68.3% | -33.0% | -7.3% | 0.6% | 60.5% | -233.4% |
| ROIC | -0.0% | -0.0% | -24.6% | -81.0% | -160.3% | -150.3% | -66.5% | 6.1% | -13.3% | — | -165.2% |
| ROCE | -0.0% | -0.0% | -30.0% | -346.2% | -91.1% | -76.8% | -35.8% | 3.9% | -12.0% | 428.9% | — |
SCNX Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $24M ($24M total debt minus $308096 cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.04 | 12.47 | 4.62 | 0.33 | 0.07 | 0.24 | 1.00 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | 4.54 | 12.68 | 1.49 | — |
| Net Debt / Equity | — | 0.00 | 0.04 | 12.47 | 1.43 | -0.50 | -0.61 | -0.45 | -0.03 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | -8.52 | -0.38 | 1.08 | — |
| Debt / FCF | — | — | — | — | — | — | — | -31.48 | -0.10 | 2.81 | — |
| Interest Coverage | -9.66 | -9.66 | -13.06 | -6.42 | -6.15 | -224.34 | -85.29 | -4.34 | 1.16 | 2.84 | -6.74 |
SCNX Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Scienture Holdings, Inc.'s current ratio of 2.89x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 0.24x to 2.89x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.89 | 2.89 | 0.80 | 0.24 | 0.98 | 4.72 | 10.95 | 7.30 | 1.70 | 1.16 | 0.23 |
| Quick Ratio | 2.82 | 2.82 | 0.80 | 0.24 | 0.94 | 4.66 | 9.46 | 7.19 | 1.61 | 1.16 | 0.23 |
| Cash Ratio | 0.00 | 0.00 | 0.04 | 0.00 | 0.51 | 3.37 | 7.03 | 5.51 | 1.01 | 0.35 | 0.01 |
| Asset Turnover | — | 0.00 | 0.00 | 0.11 | 2.76 | 1.72 | 1.75 | 1.33 | 1.72 | 4.75 | 7.36 |
| Inventory Turnover | 0.00 | 0.00 | — | 1358.26 | 72.20 | 91.39 | 9.08 | 45.20 | 5.62 | — | — |
| Days Sales Outstanding | — | 829882.42 | 14557.68 | 675.68 | 22.43 | 36.13 | 40.35 | 38.88 | 41.31 | 39.78 | 43.99 |
SCNX Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Scienture Holdings, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | 67.2% | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | 163.9% | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 41.0% | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 67.2% | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $153M | $4M | $2M | $564863 | $542449 | $513708 | $395272 | $388350 | $378736 | $350499 |
Peer Comparison
Compare SCNX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 SCNXYou | $155M | -0.1 | — | — | 76.8% | -3763.8% | -0.1% | -0.0% | — |
 PRAX | $8B | -20.9 | — | — | — | — | -45.8% | -65.0% | — |
 TARS | $3B | -39.7 | — | — | 93.2% | -15.7% | -23.4% | -23.4% | — |
 NUVL | $9B | -21.1 | — | — | — | — | -36.7% | -32.5% | — |
 KALA | $79M | -1.1 | — | — | — | — | -279.2% | — | — |
 ETON | $890M | -191.1 | 217.4 | 87.3 | 53.5% | 0.1% | -18.2% | 0.2% | 7.5 |
 TLPH | $46M | -3.2 | — | — | 100.0% | -48157.1% | -114.2% | -86.8% | — |
 HROW | $2B | -306.2 | 30.9 | 37.2 | 75.1% | 14.2% | -8.5% | 12.0% | 4.4 |
 DERM | $171M | -13.2 | — | — | 59.3% | -13.2% | -44.0% | -36.8% | — |
 AYTU | $19M | -1.1 | — | — | 69.0% | -11.8% | -58.1% | -33.5% | — |
 PRGO | $1B | -1.0 | 7.1 | 9.8 | 35.1% | 8.1% | -39.3% | 3.7% | 5.8 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 16 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
SCNX — Frequently Asked Questions
Quick answers to the most common questions about buying SCNX stock.
What is Scienture Holdings, Inc.'s P/E ratio?
Scienture Holdings, Inc.'s current P/E ratio is -0.1x. The historical average is 2.4x.
What is Scienture Holdings, Inc.'s ROE?
Scienture Holdings, Inc.'s return on equity (ROE) is -0.1%. The historical average is -67.6%.
Is SCNX stock overvalued?
Based on historical data, Scienture Holdings, Inc. is trading at a P/E of -0.1x. Compare with industry peers and growth rates for a complete picture.
What are Scienture Holdings, Inc.'s profit margins?
Scienture Holdings, Inc. has 76.8% gross margin and -3763.8% operating margin.